ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Massachusetts » Geriatric Medicine

Top Geriatric Medicine Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID BARRASSO M.D.

Geriatric Medicine

43,763

$2.17M

874
782 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $48

IRVING RESTITUYO M.D.

Geriatric Medicine

41,323

$2.4M

970
757 are 65+

16%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$58
Average prescription price

Avg: $48

AHMET DIRICAN MD

Geriatric Medicine

36,100

$2.28M

556
493 are 65+

18%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $48

HOOSHANG POOR

Geriatric Medicine

30,874

$1.92M

545
454 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$62
Average prescription price

Avg: $48

SAEID ELMI M.D.

Geriatric Medicine

30,516

$1.66M

641
545 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$55
Average prescription price

Avg: $48

STEPHEN BRESNAHAN MD

Geriatric Medicine

29,835

$1.52M

776
690 are 65+

5%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $48

ROGER SCHUTT D.O.

Geriatric Medicine

27,883

$1.33M

535
444 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $48

CHARLES HINES M.D.

Geriatric Medicine

19,537

$1.3M

424
391 are 65+

19%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$66
Average prescription price

Avg: $48

RICHARD MARQUIS M.D.

Geriatric Medicine

19,526

$958K

540
492 are 65+

14%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $48

ELISABETH BRODERICK MD

Geriatric Medicine

16,831

$468

360
279 are 65+

21%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$0
Average prescription price

Avg: $48

SHARMAN GINGRICH M.D.

Geriatric Medicine

16,481

$851K

268
243 are 65+

14%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $48

ADAM BURROWS M.D.

Geriatric Medicine

16,180

$1,296

205
188 are 65+

19%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$0
Average prescription price

Avg: $48

MARK OSTREM MD

Geriatric Medicine

15,788

$1.22M

354
248 are 65+

16%
patients receiving schedule two controlled substances

Avg: 10%

14%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$77
Average prescription price

Avg: $48

VICTOR SALDANHA M.D.

Geriatric Medicine

14,908

$738K

298
268 are 65+

13%
patients receiving schedule two controlled substances

Avg: 10%

4%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $48

W. VINCENT PERRELLI MD

Geriatric Medicine

14,112

$1.4M

333
318 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 22%

$99
Average prescription price

Avg: $48

DAVID DUHME M.D.

Geriatric Medicine

13,986

$780K

276
239 are 65+

22%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $48

WAYNE SALTSMAN M.D.

Geriatric Medicine

13,518

$501K

373
364 are 65+

23%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$37
Average prescription price

Avg: $48

JEFFREY BURL MD

Geriatric Medicine

13,384

$659K

297
283 are 65+

22%
patients receiving schedule two controlled substances

Avg: 10%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $48

EFRAIN TORRES M.D.

Geriatric Medicine

12,539

$616K

494
333 are 65+

24%
patients receiving schedule two controlled substances

Avg: 10%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $48

WILLIAM ZINN

Geriatric Medicine

12,378

$628K

424
305 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $48

HARRY WARD M.D.

Geriatric Medicine

12,312

$685K

406
380 are 65+

5%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $48

GABRIEL BRANDEIS M.D.

Geriatric Medicine

12,048

$623K

271
263 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $48

ALLEN WALTMAN M.D.

Geriatric Medicine

11,435

$556K

243
198 are 65+

25%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$49
Average prescription price

Avg: $48

ASMA TAHIR MD

Geriatric Medicine

11,375

$618K

276
255 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$54
Average prescription price

Avg: $48

ADNAN HAIDER MD

Geriatric Medicine

11,352

$480K

325
306 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$42
Average prescription price

Avg: $48

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank